Colorectal Cancer
Colonoscopy screening gap ‘could potentially be extended’ to 15 years for average-risk CRC
The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.
‘Startling’ disparities in cancer deaths for Native Hawaiians, other Pacific Islanders
Native Hawaiian and other Pacific Islander individuals in the United States are two to three times more likely to die of certain cancers than white individuals, according to an American Cancer Society report.
Aspirin may have ‘direct role’ in augmenting the immune system to fight colorectal cancer
Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.
Nearly 60 million individuals aged 45 to 85 years are eligible for CRC screening in the US
Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.
CRC rarely found in older adults at surveillance colonoscopy regardless of polyp history
Detection of colorectal cancer was “rare” at surveillance colonoscopy among patients aged 70 to 85 years, and although detection of advanced neoplasia was higher, overall yields did not increase significantly with age, researchers reported.
National Comprehensive Cancer Network appoints board of directors chair, vice chair
Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.
Blood-based CRC screening ‘less effective, more costly’ vs. recommended strategies
Triennial blood-based screening for colorectal cancer was not cost-effective compared with existing screening modalities such as colonoscopy, fecal immunochemical test and stool DNA testing, according to microsimulation model projections.
Follow-up measure after stool-based CRC test feasible, could ensure ‘complete’ screening
A quality performance measure that tracks follow-up colonoscopy rates within 6 months of an abnormal stool-based screening test was feasible and had a median reliability of 94.5% across health care organizations, according to researchers.
Prediction model could prioritize high-risk patients awaiting surveillance colonoscopy
A multivariable risk prediction model “may be useful” for prioritizing patients at highest risk for colorectal cancer and awaiting surveillance colonoscopy when demand for the procedure is high, according to research in Gastro Hep Advances.
Coffee consumption may reduce colorectal cancer recurrence, all-cause mortality
Coffee consumption may reduce risk for colorectal cancer recurrence and all-cause mortality, according to research published in the International Journal of Cancer.